This federal contract award, identified as SPE2DB22D3016|SPE2DB25FAHM5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not designated with a set-aside, is a Delivery Order with a Firm Fixed Price pricing type, valued at $5,836.92, and has an ultimate completion date of December 27, 2024.
The contract is for the supply of Lurasidone HCl 40 mg Tablets, a pharmaceutical product used for the treatment of mental health conditions. Amerisourcebergen, as the prime contractor, is responsible for providing this medication to support federal healthcare programs, particularly within the military and veterans' healthcare systems.
This contract award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/27/25, 9:50 AM